Man Group’s Tectonic Therapeutic TECX Stock Holding History

Man Group’s Portfolio TECX Stock Details TECX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-529	Closed	-$329K	–	2149
2018 Q3	$329K	Buy	+529	New	+$235K	﹤0.01%	1929

Other funds holding TECX

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

SHI

SV Health Investors Boston, Massachusetts $32.3M AUM 20.15% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ACM

Aisling Capital Management New York $476M AUM 128.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Man Group's TECX Position: Q4 2018 in Review

Man Group sold out of Tectonic Therapeutic (TECX) in Q4 2018, closing a stake of 529 shares — an estimated $329K sold.

Man Group first reported a position in TECX in Q3 2018 and held it in 1 quarter. The position peaked at $329K in Q3 2018. 59 funds tracked by Wall St. Rank hold TECX as of Q4 2018.

Man Group reported no remaining Tectonic Therapeutic position as of Q4 2018 after selling out during the quarter.
Man Group sold 529 Tectonic Therapeutic shares in Q4 2018, an estimated $329K.
Man Group first reported a position in Tectonic Therapeutic in Q3 2018 and held it in 1 quarter.
Man Group's Tectonic Therapeutic position peaked at $329K in Q3 2018.
59 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q4 2018.

Based on Man Group's 13F filing for Q4 2018, filed 14 Feb 2019.